Laboratorio Reig Jofre, S.A.

MCE RJF.MC

Laboratorio Reig Jofre, S.A. Free Cash Flow Yield on January 14, 2025: 3.38%

Laboratorio Reig Jofre, S.A. Free Cash Flow Yield is 3.38% on January 14, 2025, a -7.60% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Laboratorio Reig Jofre, S.A. 52-week high Free Cash Flow Yield is 3.77% on February 21, 2024, which is 11.42% above the current Free Cash Flow Yield.
  • Laboratorio Reig Jofre, S.A. 52-week low Free Cash Flow Yield is 2.66% on October 14, 2024, which is -21.33% below the current Free Cash Flow Yield.
  • Laboratorio Reig Jofre, S.A. average Free Cash Flow Yield for the last 52 weeks is 3.20%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
MCE: RJF.MC

Laboratorio Reig Jofre, S.A.

CEO Mr. Ignasi Biosca Reig
IPO Date Nov. 29, 2002
Location Spain
Headquarters Gran Capita, 10
Employees 1,331
Sector Health Care
Industries
Description

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Despí, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.

Similar companies

PHM.MC

Pharma Mar, S.A.

USD 77.86

1.89%

ROVI.MC

Laboratorios Farmaceuticos Rovi, S.A.

USD 59.78

-0.59%

FAE.MC

Faes Farma, S.A.

USD 3.46

-1.45%

ALM.MC

Almirall, S.A.

USD 8.60

3.71%

ORY.MC

Oryzon Genomics S.A.

USD 1.51

-0.07%

StockViz Staff

January 15, 2025

Any question? Send us an email